BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Keryx Biopharmaceuticals Announces Positive Data Of KRX-0401 (Perifosine) In Patients With Advanced Renal Cell Carcinoma

  June 5, 2006

   · 

  8 min read
• Drug Development

  Genzyme Corporation And Berlex Oncology Announce Interim Results Of Campath In First-Line Study Of Chronic Lymphocytic Leukemia At American Society of Clinical Oncology

  June 5, 2006

   · 

  12 min read
• Drug Development

  Cell Genesys, Inc. Reports Long-Term Follow-Up Data From Phase 2 Trial Of GVAX(R) Immunotherapy For Leukemia In Chronic Myelogenous Leukemia

  June 5, 2006

   · 

  5 min read
• Drug Development

  Bristol-Myers Squibb Company Release: Data From A Randomized Phase II Study Of Dasatinib Or 800 Mg/Day Imatinib- Mesylate (Gleevec(R)) Presented At The 42nd Annual Meeting Of The American Society of Clinical Oncology

  June 5, 2006

   · 

  2 min read
• Drug Development

  Eli Lilly and Company Breast Cancer Studies Explore Potential Role Of Pharmacogenomics In Customizing Chemotherapy

  June 5, 2006

   · 

  7 min read
• Drug Development

  Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Release: VELCADE(R) (Bortezomib) For Injection May Offer New Standard Of Care iI Relapsed/Refractory Mantle Cell Lymphoma

  June 5, 2006

   · 

  7 min read
• Drug Development

  Wyeth Announces Preliminary Results Of An Ongoing Study Of Temsirolimus For The Treatment Of Advanced Renal Cell Carcinoma As Presented At American Society of Clinical Oncology

  June 5, 2006

   · 

  5 min read
• Drug Development

  Introgen Therapeutics, Inc.'s INGN 241 In Combination With Tarceva Inhibits Tumor Growth

  June 5, 2006

   · 

  5 min read
• Drug Development

  Eli Lilly and Company Release: Updated Analysis In Second-Line Treatment Of Lung Cancer Trial Confirms Similar Survival For Alimta(R) And Docetaxel

  June 5, 2006

   · 

  8 min read
• Business

  The National Surgical Adjuvant Breast & Bowel Project And Genomic Health, Inc. Announce Positive Early Results In Development Of Genomic Test For Colon Cancer Prognosis

  June 5, 2006

   · 

  5 min read